Treatment of cerebrovascular disease with anticoagulants and platelet anti-aggregants

Introduction. The use of anticoagulants and platelet anti-aggregants is one of the basic features of the management of patients with cerebrovascular disease. Development. The indications for the use of these agents have evolved from initial empirical use based on anecdotic evidence to current recomm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Ameriso, S.F.
Formato: JOUR
Materias:
Anti-aggregant
Anticoagulant
Cerebral infarction
Cerebrovascular disease
Treatment
acetylsalicylic acid
anticoagulant agent
antithrombocytic agent
clopidogrel
ticlopidine
warfarin
anticoagulant therapy
cerebrovascular disease
clinical trial
conference paper
human
secondary prevention
stroke
Anticoagulants
Brain Ischemia
Clinical Trials
Humans
Platelet Aggregation Inhibitors
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_02100010_v29_n12_p1285_Ameriso
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Ejemplares similares